| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |